BMO Capital Maintains a Sell Rating on Eli Lilly & Co (LLY) and $73.0 Target; Nike (NKE) Had 26 Bulls

August 16, 2017 - By Nellie Frank

Among 42 analysts covering Nike Inc. (NYSE:NKE), 26 have Buy rating, 2 Sell and 14 Hold. Therefore 62% are positive. Nike Inc. had 168 analyst reports since July 29, 2015 according to SRatingsIntel. The company was initiated on Tuesday, October 11 by Susquehanna. B. Riley & Co maintained Nike Inc (NYSE:NKE) on Friday, October 16 with “Buy” rating. The company was maintained on Wednesday, September 28 by Citigroup. Credit Suisse maintained Nike Inc (NYSE:NKE) on Wednesday, September 28 with “Outperform” rating. On Monday, June 19 the stock rating was maintained by Barclays Capital with “Buy”. The stock has “Overweight” rating by Morgan Stanley on Wednesday, March 23. The rating was maintained by Stifel Nicolaus on Wednesday, June 29 with “Buy”. The firm earned “Buy” rating on Wednesday, June 29 by Citigroup. On Wednesday, March 23 the stock rating was maintained by Goldman Sachs with “Buy”. The firm has “Buy” rating by Jefferies given on Thursday, December 17. See Nike Inc (NYSE:NKE) latest ratings:

15/08/2017 Broker: Jefferies Rating: Buy New Target: $75.0 Maintain
04/08/2017 Broker: Cowen & Co Rating: Hold New Target: $54.0000 Maintain
27/07/2017 Broker: Piper Jaffray Rating: Buy Maintain
21/07/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $66.0000 Maintain
21/07/2017 Broker: Guggenheim Rating: Buy Maintain
21/07/2017 Broker: Piper Jaffray Rating: Hold New Target: $53.0000 Maintain
20/07/2017 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Overweight Upgrade
19/07/2017 Broker: Needham Rating: Hold Initiates Coverage On
17/07/2017 Broker: Nomura Rating: Buy Old Target: $60 New Target: $62 Maintain
14/07/2017 Broker: Susquehanna Rating: Buy New Target: $64.0000 Maintain

Among 19 analysts covering Eli Lilly and Company (NYSE:LLY), 13 have Buy rating, 1 Sell and 5 Hold. Therefore 68% are positive. Eli Lilly and Company has $125 highest and $64 lowest target. $92.71’s average target is 14.90% above currents $80.69 stock price. Eli Lilly and Company had 65 analyst reports since July 23, 2015 according to SRatingsIntel. Jefferies maintained the shares of LLY in report on Thursday, July 14 with “Buy” rating. The rating was maintained by SunTrust with “Buy” on Wednesday, June 14. The rating was upgraded by Goldman Sachs on Tuesday, September 27 to “Buy”. The firm has “Overweight” rating by Morgan Stanley given on Friday, December 16. The rating was maintained by Bank of America on Friday, September 18 with “Buy”. The stock of Eli Lilly and Co (NYSE:LLY) has “Buy” rating given on Monday, December 7 by Deutsche Bank. The stock of Eli Lilly and Co (NYSE:LLY) has “Buy” rating given on Friday, June 16 by Jefferies. On Friday, November 25 the stock rating was downgraded by BMO Capital Markets to “Market Perform”. The rating was maintained by Cowen & Co with “Outperform” on Monday, August 24. The rating was maintained by Jefferies with “Buy” on Friday, September 18.

Eli Lilly and Company is engaged in drug manufacturing business. The company has market cap of $88.84 billion. The Firm discovers, develops, makes and markets products in two divisions: human pharmaceutical products and animal health products. It has a 34.97 P/E ratio. The Company’s human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists.

Investors sentiment decreased to 0.97 in 2016 Q4. Its down 0.11, from 1.08 in 2016Q3. It worsened, as 84 investors sold Eli Lilly and Co shares while 380 reduced holdings. 103 funds opened positions while 348 raised stakes. 809.72 million shares or 0.51% more from 805.63 million shares in 2016Q3 were reported. Pax Mngmt Limited Liability Corporation invested 0.03% in Eli Lilly and Co (NYSE:LLY). Gamble Jones Investment Counsel owns 18,214 shares or 0.15% of their US portfolio. Broderick Brian C holds 9,239 shares. Reynders Mcveigh Cap Management Limited Company invested 0.07% in Eli Lilly and Co (NYSE:LLY). Balasa Dinverno And Foltz Limited Com invested 0.04% in Eli Lilly and Co (NYSE:LLY). Stearns Services Gp invested in 0.1% or 5,272 shares. Employees Retirement Sys Of Texas holds 0.46% or 458,600 shares. The New York-based Fred Alger Mngmt has invested 0.38% in Eli Lilly and Co (NYSE:LLY). Appleton Prns Ma invested 0.12% of its portfolio in Eli Lilly and Co (NYSE:LLY). Ray Gerald L & Assocs reported 0.39% in Eli Lilly and Co (NYSE:LLY). Moreover, First Natl Bank Of Omaha has 0.57% invested in Eli Lilly and Co (NYSE:LLY). Rathbone Brothers Public Limited Co has 0.36% invested in Eli Lilly and Co (NYSE:LLY) for 97,440 shares. Piedmont Inv Advsrs Ltd Liability Com holds 0% in Eli Lilly and Co (NYSE:LLY) or 235,135 shares. United Advisers reported 0.05% of its portfolio in Eli Lilly and Co (NYSE:LLY). Nomura Inc invested in 89,984 shares or 0.02% of the stock.

The stock decreased 1.25% or $1.02 on August 16, reaching $80.69. About 3.16 million shares traded. Eli Lilly and Co (NYSE:LLY) has risen 4.70% since August 16, 2016 and is uptrending. It has underperformed by 12.00% the S&P500.

Since February 17, 2017, it had 0 buys, and 4 insider sales for $21.83 million activity. On Monday, June 12 the insider Barnes Melissa S sold $153,482. 25,000 shares were sold by Conterno Enrique A, worth $2.07M on Thursday, May 4. Harrington Michael J sold $1.83M worth of stock. The insider LILLY ENDOWMENT INC sold $17.78 million.

Since March 24, 2017, it had 1 buy, and 5 sales for $14.79 million activity. Another trade for 100,000 shares valued at $5.55 million was made by PARKER MARK G on Monday, April 3. 1,000 shares valued at $56,301 were bought by LECHLEITER JOHN C on Friday, March 24. SPRUNK ERIC D sold $2.85 million worth of stock.

NIKE, Inc. is engaged in the design, development, marketing and selling of athletic footwear, apparel, equipment, accessories and services. The company has market cap of $96.09 billion. The Company’s operating divisions include North America, Western Europe, Central & Eastern Europe, Greater China, Japan and Emerging Markets. It has a 23.37 P/E ratio. The Company’s portfolio brands include the NIKE Brand, Jordan Brand, Hurley and Converse.